Compound with glycidic structure active in the therapy of systemic and local inflammation

Compounds of the general formula (I) and (II) (including formulae (III) to (V)), wherein X=-CH2-, -O-, -S- n=0-10 Y=-NH-, -NHSO2-, -NHSO-, -NHCO-, -S-, -O-, -CH-CH-R1-R7, equal or different can be hydrogen, alkyl C1-C4, alkenyl C2-C4, cycloalkyl C3-C7, aryl or heteroaryl; may be substituted with one or more alkyl C1-C4, alkoxyl C1-C4, alkylthio C1-C4 or halogens; -NR8R9, where R8 e R9, equal or different, represent hydrogen, alkyl C1-C4, alkenyl C2-C4, cycloalkyl C3-C7, aryl or heteroaryl, may be substituted with one or more C1-C4, alkoxyl C1-C4, alkylthio C1-C4 or halogens; -(CH2)n, -COOR10, with n'=0-4 and R3=hydrogen or alkyl C1-C4, and their addition salts with organic and inorganic acids, or alkaline and alkaline earth metal or ammonium ions, with the exclusion of the compounds having the following formulae ((VI) to (IX)).